Brief: Endo Announces Approval Of XCOPRI In Canada
29/06/2023 12:35
June 29 (Reuters) - Endo International PLC ENDPQ.PK :
* ENDO ANNOUNCES APPROVAL OF XCOPRI™ (CENOBAMATE TABLETS) IN
CANADA
* ENDO INTERNATIONAL PLC - PALADIN LABS EXPECTS TO LAUNCH
XCOPRI
IN DECEMBER 2023
Source text for Eikon: ID:nPnc0rgmSa
Further company coverage: ENDPQ.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endo International
See all newsBrief: Endo International PLC Files For Offering Of Up To 31.1 Million Common Shares By The Selling Stockholders - SEC Filing
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes